Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Feb;10(1):30-37.
doi: 10.1093/ckj/sfw060. Epub 2016 Jul 4.

Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study

Affiliations
Comment

Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study

Benjamin Brigant et al. Clin Kidney J. 2017 Feb.

Retraction in

Abstract

Background: MicroRNAs (miRNAs) are innovative and informative blood-based biomarkers involved in numerous pathophysiological processes. In this study and based on our previous experimental data, we investigated miR-126, miR-143, miR-145, miR-155 and miR-223 as potential circulating biomarkers for the diagnosis and prognosis of patients with chronic kidney disease (CKD). The primary objective of this study was to assess the levels of miRNA expression at various stages of CKD.

Methods: RNA was extracted from serum, and RT-qPCR was performed for the five miRNAs and cel-miR-39 (internal control).

Results: Serum levels of miR-143, -145 and -223 were elevated in patients with CKD compared with healthy controls. They were further increased in chronic haemodialysis patients, but were below control levels in renal transplant recipients. In contrast, circulating levels of miR-126 and miR-155 levels, which were also elevated in CKD patients, were lower in the haemodialysis group and even lower in the transplant group. Four of the five miRNA species were correlated with estimated glomerular filtration rate, and three were correlated with circulating uraemic toxins.

Conclusions: This exploratory study suggests that specific miRNAs could be biomarkers for complications of CKD, justifying further studies to link changes of miRNA levels with outcomes in CKD patients.

Keywords: CKD; haemodialysis; microRNAs; renal transplantation; serum biomarkers.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Circulating uraemic toxin levels (A) and miRNAs levels (B) in healthy controls, CKD patients, chronic haemodialysis patients and renal transplant recipients. Sera were collected from patients with CKD Stage III–V (n = 31), haemodialysis patients (n = 40), healthy volunteers (n = 38) and renal transplant recipients (n = 40). miRNA levels were assessed using Taqman RT-qPCR. Each sample was assayed in triplicate. Data are expressed as mean ± SEM. *,°,$ P < 0.05; **,°° P < 0.01; ***,°°° P < 0.001.

Comment on

Similar articles

Cited by

References

    1. Vanholder R, Massy Z, Argiles A et al. . Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20: 1048–1056 - PubMed
    1. Vanholder R, De Smet R, Glorieux G et al. . Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934–1943 - PubMed
    1. Barreto FC, Barreto DV, Liabeuf S et al. . Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 2009; 4: 1551–1558 - PMC - PubMed
    1. Dou L, Sallee M, Cerini C et al. . The cardiovascular effect of the uremic solute indole-3 acetic acid. J Am Soc Nephrol 2015; 26: 876–887 - PMC - PubMed
    1. Lin CJ, Wu V, Wu PC et al. . Meta-analysis of the associations of p-cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure. PLoS One 2015; 10: e0132589. - PMC - PubMed

LinkOut - more resources